These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 21745806)

  • 1. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.
    Bigé N; Lanternier F; Viard JP; Kamgang P; Daugas E; Elie C; Jidar K; Walker-Combrouze F; Peraldi MN; Isnard-Bagnis C; Servais A; Lortholary O; Noël LH; Bollée G
    Nephrol Dial Transplant; 2012 Mar; 27(3):1114-21. PubMed ID: 21745806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-associated kidney glomerular diseases: changes with time and HAART.
    Lescure FX; Flateau C; Pacanowski J; Brocheriou I; Rondeau E; Girard PM; Ronco P; Pialoux G; Plaisier E
    Nephrol Dial Transplant; 2012 Jun; 27(6):2349-55. PubMed ID: 22248510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and histological response of HIV-associated kidney disease to antiretroviral therapy in South Africans.
    Fabian J; Naicker S; Goetsch S; Venter WD
    Nephrol Dial Transplant; 2013 Jun; 28(6):1543-54. PubMed ID: 23444185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and natural history of HIV-associated nephropathy.
    Atta MG
    Adv Chronic Kidney Dis; 2010 Jan; 17(1):52-8. PubMed ID: 20005489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management.
    Atta MG; Lucas GM; Fine DM
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):365-71. PubMed ID: 18588500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival experience of peritoneal dialysis patients with human immunodeficiency virus: a 17-year retrospective study.
    Khanna R; Tachopoulou OA; Fein PA; Chattopadhyay J; Avram MM
    Adv Perit Dial; 2005; 21():159-63. PubMed ID: 16686310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.
    Wikman P; Safont P; Del Palacio M; Moreno A; Moreno S; Casado JL
    Nephrol Dial Transplant; 2013 Aug; 28(8):2073-81. PubMed ID: 23739150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy.
    Ando M; Yanagisawa N; Ajisawa A; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2011 Oct; 26(10):3224-9. PubMed ID: 21372250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance hemodialysis in patients with HIV-associated nephropathy.
    Dave MB; Shabih K; Blum S
    Clin Nephrol; 1998 Dec; 50(6):367-74. PubMed ID: 9877110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The methods of therapy ESRD patients infected with the human immunodeficiency virus-HIV].
    Gozdowska J; Durlik M
    Przegl Lek; 2008; 65(2):82-6. PubMed ID: 18663906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22 years.
    Bickel M; Marben W; Betz C; Khaykin P; Stephan C; Gute P; Haberl A; Knecht G; Wolf T; Brodt HR; Geiger H; Herrmann E; Jung O
    HIV Med; 2013 Mar; 14(3):127-35. PubMed ID: 22994610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-associated nephropathy: a brief review.
    Lu TC; Ross M
    Mt Sinai J Med; 2005 May; 72(3):193-9. PubMed ID: 15915314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.
    Choi AI; Rodriguez RA; Bacchetti P; Volberding PA; Havlir D; Bertenthal D; Bostrom A; O'Hare AM
    Clin Infect Dis; 2007 Dec; 45(12):1633-9. PubMed ID: 18190326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.
    Lohse N; Kronborg G; Gerstoft J; Larsen CS; Pedersen G; Pedersen C; Sørensen HT; Obel N
    Clin Infect Dis; 2006 Jan; 42(1):136-44. PubMed ID: 16323104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients.
    Amara S; Dezube BJ; Cooley TP; Pantanowitz L; Aboulafia DM
    Clin Infect Dis; 2006 Nov; 43(9):1198-205. PubMed ID: 17029142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy.
    Winston JA; Burns GC; Klotman PE
    Semin Nephrol; 1998 Jul; 18(4):373-7. PubMed ID: 9692350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.